GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Net Margin %

Mankind Pharma (BOM:543904) Net Margin % : 17.41% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Mankind Pharma's Net Income for the three months ended in Dec. 2023 was ₹4,538 Mil. Mankind Pharma's Revenue for the three months ended in Dec. 2023 was ₹26,070 Mil. Therefore, Mankind Pharma's net margin for the quarter that ended in Dec. 2023 was 17.41%.

The historical rank and industry rank for Mankind Pharma's Net Margin % or its related term are showing as below:

BOM:543904' s Net Margin % Range Over the Past 10 Years
Min: 17.57   Med: 18.42   Max: 20.36
Current: 18.26


BOM:543904's Net Margin % is ranked better than
85.99% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.25 vs BOM:543904: 18.26

Mankind Pharma Net Margin % Historical Data

The historical data trend for Mankind Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Net Margin % Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22
Net Margin %
17.57 20.36 18.42

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.30 13.59 18.88 18.50 17.41

Competitive Comparison of Mankind Pharma's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mankind Pharma's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's Net Margin % falls into.



Mankind Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Mankind Pharma's Net Margin for the fiscal year that ended in Mar. 2022 is calculated as

Net Margin=Net Income (A: Mar. 2022 )/Revenue (A: Mar. 2022 )
=14334.75/77815.55
=18.42 %

Mankind Pharma's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=4537.6/26069.589
=17.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mankind Pharma  (BOM:543904) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Mankind Pharma Net Margin % Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mankind Pharma (BOM:543904) Business Description

Traded in Other Exchanges
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines